• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Health 2.0 Europe - Voluntis Deep Dive
 

Health 2.0 Europe - Voluntis Deep Dive

on

  • 1,732 views

 

Statistics

Views

Total Views
1,732
Views on SlideShare
1,714
Embed Views
18

Actions

Likes
0
Downloads
0
Comments
0

2 Embeds 18

http://www.health2con.com 13
http://www.slideshare.net 5

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Health 2.0 Europe - Voluntis Deep Dive Health 2.0 Europe - Voluntis Deep Dive Presentation Transcript

    • Introducing diabeo Mobile & web diabetes telecare system Health 2.0 conference – Paris, April 2010 Lydie CANIPEL, CERITD Géraud RABEONY, VOLUNTIS
    • Type 1 diabetes management – insulin therapy Quantités de Amount of glucides carbohydrates Insuline rapide Rapid-acting insulin Insuline lente Long-acting insulin 8h 12 h 20 h 24 h © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 2
    • A day in a life of a diabetic … A typical day A health care professional who must, in 20 min every 6 months, analyze 180 such days Glucose readings at least 4/day Calculate Identify servings insulin doses How to improve this follow-up? Adaptation / Is the electronic logbook the answer? Physical activity © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 3
    • A day in a life of a diabetic … with diabeo A typical day with DIABEO Glucose readings at least 4/day Physical activity Servings identification Medical Insulin dose adjustment prescription © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 4
    • Scientific validation of diabeo using Evidence-based medicine 2005: « PDAphone1 » : Feasibility study (CERITD, 10 patients, 3 months) Mono- center 2006: « PDAphone2 » Validation study (CERITD, 30 patients, 4 months) 2007-2009: « TELEDIAB1 » : Multi-center study (RCT in 20 French hospitals, 180 patients) to evaluate the clinical and economic impact of the system on T1DM management Multi- 2008-2011: « TELEDIAB2 » Multi-center study (RCT in 20+ hospitals & center PCP practices, 180 patients) to evaluate the clinical and economic impact of the system on T2DM management 2010-2013: « MEOS » Electronic Medical Records online, managed by the diabetologist and the patient 2011-2013: « TELESAGE1 » large-scale cohort study The TELEDIAB1 and TELEDIAB2 studies have been conducted in partnership with Orange Healthcare and the pharmaceutical industry © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 5
    • TELEDIAB1 study results Improved glycemic control with Diabeo… Without Improved glycemic control increasing without increasing healthcare Modification of HbA1c at Month 6 hypoglycemic professionals’ clinical time by patient group events -0,9 pt HbA1c More response in the DIABEO group 3/4 of patients want to keep using Diabeo Usual care DIABEO + usual care DIABEO + teleconsultations -10% of HbA1c= -10% of HbA1c= - 25 % of risk of -39 % of risk of microalbuminuria retinopathy development development © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 6
    • Introducing diabeo Innovative mobile & web diabetes management solution based on the software platform Developed through a scientific collaboration between Voluntis and CERITD (diabetes research institute led by Dr Guillaume CHARPENTIER) Supported by the telemedicine working group of SFD (French Diabetology Society) Endorsed by AFD (French Diabetics’ Association) Winner of the 2007 Innovation Trophies (Orange Business Services, Syntec Informatique) © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 7
    • Overview of the diabeo system Researchers Database export Patient App Diabetes telecare system HCP Patient Powered by Portals HCPs (T1 / T2) (PCP / Endo / CDE) Patient Portal © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 8
    • Patient-HCP interactions enabled by diabeo Diabetes telecare system Patient Powered by With a smartphone Healthcare professional WIth access to the Internet Phone-based teleconsultations © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 9
    • Patient mobile interface © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 10
    • Patient mobile interface My Stats © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 11
    • Data synchronization with the Medpassport web server © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 12
    • Patient logbook (weekly view) © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 13
    • Goal setting Goals Pre-meal targets Minimum goal Maximum goal Post-meal targets Maximum goal Bedtime targets Minimum goal Maximum goal Update © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 14
    • Treatment profile © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 15
    • Adjustment of insulin dose parameters (T1DM) © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 16
    • Summary of diabeo’s benefits For patients • Assistance in the insulin dosage process, higher dietary freedom, modern vs. paper logbook • Reinforced link with the health care team For healthcare professionals • Tool to reinforce the treatment and achieve better glycemic control among patients • Productivity gains in the clinical care process (e.g. instant access to patient data) and efficient system for teleconsultations For payers • Short-term savings due to avoided transportation and absenteeism costs • Mid-term savings due to avoided hospitalizations thanks to the prevention of complications For researchers • Highly-valuable real-life database which will serve to optimize treatment recommendations © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 17
    • Current status and near-term perspectives BETA test ongoing for T1 patients since H1 2009 Preparing the commercial launch for T1 patients Completing the scientific evaluation of diabeo for T2 patients Launching TELESAGE1 (large-scale cohort study) Internationalizing diabeo (primary focus on Europe & USA) Filing for reimbursement by health care payers … Stay informed by contacting us at www.diabeo.com ! © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 18
    • Thanks for your attention! To contact us: Géraud RABEONY Lydie CANIPEL Sr Sales Managing Director geraud.rabeony@voluntis.com direction@ceritd.com www.voluntis.com www.diabeo.com © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 19
    • Back-up slides
    • diabeo usage data 120,00% % of daily data entered by patients (glucose levels, carb counts, insulin doses) (n = 30) 100,00% 80,00% 60,00% 40,00% 20,00% 0,00% 1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 Average filling rate = 96.9%, 22 out of 30 have a rate > 99,1% No noticeable decrease of usage of the system over the 4 months of the study Source: Voluntis © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 21
    • Blood sugar control with diabeo Mean glycaemic profile during the 1st month of study in the population (n=35) 14.0 12.0 Blood glucose value (mmol/l) 10.0 8.0 6.0 4.0 2.0 Breakfast Lunch Dinner 0.0 FBG PP BG FBG PP BG FBG PP BG Nocturnal BG (n=1072) (n=623) (n=992) (n=666) (n=1028) (n=642) (n=370) Source: CERITD © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 22
    • Dietary freedom with diabeo Source: CERITD Patients ate the same mean amount of carbohydrates at lunch and dinner in half of the cases. The rest of the time, they modified the number of 20g carbohydrate portions of their meal from 1 to 4 portions and even more. © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 23
    • Patient satisfaction with diabeo « Regarding the general interest of the program, have you been… » a - Très satisfait 4% 88% 8% patients b - Assez satisfait c - Peu satisfait 29% 59% d - Pas du tout satisfait. (vide) « In routine, how long would you use the system ? » a - Pour quelques mois seulement 6% 4% (apprentissage de l’IF par ex.) b -Pour une durée indéterminée (remplacement intégral du carnet papier) 90% (vide) Source: enquête patients intermédiaire dans le cadre de l’étude TELEDIAB1 (N=49, données recueillies en novembre 2008) © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 24
    • Patients’ willingness to pay out-of-pocket for diabeo « If this service was proposed for a fee, would you accept to suscribe to it? » 12% % patients répondant Oui 29% Non 59% (vide) 50% « In addition to the mobile phone and the 45% Between 10 and 15 € GPRS data connections, we estimated the 40% per month (78%) cost of the service at around 15 € per 35% month. 30% What monthly fee would you be 25% Sé ready to pay for the services which 20% 15% would include the use of the mobile 10% software and its potential upgrades, the 5% management of the web site and the 0% periodic medical follow-up? » 0 10 15 20 25 30 (vide) Euros Source: enquête patients intermédiaire dans le cadre de l’étude TELEDIAB1 (N=49, données recueillies en novembre 2008) © 2010 VOLUNTIS & CERITD. All Rights Reserved. The Voluntis and medpassport names and logos are registered trademarks of VOLUNTIS S.A. 25